Mesenchymal stem cells (MSCs) possess immunosuppressive properties, making them less likely to trigger the typical immune response associated with foreign cells. MSCs derived from umbilical cords are universally compatible and carry no risk of rejection. These cord tissue-derived MSCs are essentially “new” and immunoprivileged, meaning they are not recognized or claimed by the body’s immune system.
Furthermore. unlike treatments such as organ transplants, umbilical cord tissue-derived mesenchymal stem cells (MSCs) do not involve the use of blood products or require HLA matching. This eliminates the risk of rejection, making them a safe and universally compatible option for therapy
Stem Cell Q&A is a reoccurring series of questions and answers from regenerative health community forums across the web as well as submitted directly to TheRHA.org. Have a question? Feel free to email us at [email protected] and we’ll do our best to provider an answer and /or resource for you.
